Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ACTAVIS
EQUITY SHARE DATA
    IPCA LABS
Mar-23
ACTAVIS
Dec-18
IPCA LABS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,06216,037-   
Low Rs76810,758-   
Sales per share (Unadj.) Rs243.03,933.9-  
Earnings per share (Unadj.) Rs19.4-1,267.1-  
Cash flow per share (Unadj.) Rs29.7414.5-  
Dividends per share (Unadj.) Rs4.000-  
Avg Dividend yield %0.40-  
Book value per share (Unadj.) Rs230.316,225.6-  
Shares outstanding (eoy) m253.70332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.83.4 110.6%   
Avg P/E ratio x47.2-10.6 -446.3%  
P/CF ratio (eoy) x30.832.3 95.3%  
Price / Book Value ratio x4.00.8 481.2%  
Dividend payout %20.60-   
Avg Mkt Cap Rs m232,1204,456,026 5.2%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m12,8760-   
Avg. sales/employee Rs Th077,421.7-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-24,937.6-  
INCOME DATA
Net Sales Rs m61,6421,308,427 4.7%  
Other income Rs m1,51825,021 6.1%   
Total revenues Rs m63,1601,333,448 4.7%   
Gross profit Rs m9,03334,287 26.3%  
Depreciation Rs m2,616559,324 0.5%   
Interest Rs m48275,504 0.6%   
Profit before tax Rs m7,453-575,519 -1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0146,780 0.0%   
Tax Rs m2,534-7,293 -34.7%   
Profit after tax Rs m4,919-421,445 -1.2%  
Gross profit margin %14.72.6 559.2%  
Effective tax rate %34.01.3 2,682.5%   
Net profit margin %8.0-32.2 -24.8%  
BALANCE SHEET DATA
Current assets Rs m51,893536,648 9.7%   
Current liabilities Rs m18,058474,737 3.8%   
Net working cap to sales %54.94.7 1,160.0%  
Current ratio x2.91.1 254.2%  
Inventory Days Days5120 261.6%  
Debtors Days Days666 8.8%  
Net fixed assets Rs m34,336148,107 23.2%   
Share capital Rs m2540-   
"Free" reserves Rs m58,1670-   
Net worth Rs m58,4205,396,648 1.1%   
Long term debt Rs m6,5181,900,356 0.3%   
Total assets Rs m86,2298,436,189 1.0%  
Interest coverage x16.5-6.6 -248.6%   
Debt to equity ratio x0.10.4 31.7%  
Sales to assets ratio x0.70.2 460.9%   
Return on assets %6.3-4.1 -152.8%  
Return on equity %8.4-7.8 -107.8%  
Return on capital %12.2-4.8 -252.4%  
Exports to sales %42.90-   
Imports to sales %13.30-   
Net fx Rs m18,2570-   
CASH FLOW
From Operations Rs m8,058467,451 1.7%  
From Investments Rs m-7,250256,804 -2.8%  
From Financial Activity Rs m5,072-802,287 -0.6%  
Net Cashflow Rs m5,881-77,642 -7.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 82.88 Rs / USD

Compare IPCA LABS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: SAMRAT PHARMA  NEULAND LABS  SOURCE NATURAL FOODS  GENNEX LAB.  IOL CHEMICALS & PHARM.  



Today's Market

Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today Gift Nifty Down 79 Points | Why Adani Group Stocks are Falling | Baazar Style Retail Files for IPO | Top Buzzing Stocks Today(Pre-Open)

On Monday, Indian share markets reversed the trend as the session progressed and ended the day higher.